Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016 (2016), Article ID 5029797, 10 pages
http://dx.doi.org/10.1155/2016/5029797
Research Article

7,8-DHF Treatment Induces Cyr61 Expression to Suppress Hypoxia Induced ER Stress in HK-2 Cells

1Department of Nephrology, Affiliated Hospital of Qingdao University, Qingdao 266003, China
2Key Laboratory, Department of Otolaryngology-Head and Neck Surgery, Affiliated Hospital of Qingdao University, Qingdao 266003, China

Received 14 July 2016; Accepted 21 November 2016

Academic Editor: Decheng Yang

Copyright © 2016 Rui Ma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Case, S. Khan, R. Khalid, and A. Khan, “Epidemiology of acute kidney injury in the intensive care unit,” Critical Care Research and Practice, vol. 2013, Article ID 479730, 9 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. G. H. Tesch, “Review: serum and urine biomarkers of kidney disease: a pathophysiological perspective,” Nephrology, vol. 15, no. 6, pp. 609–616, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. I. Loeffler and G. Wolf, “The role of hypoxia and Morg1 in renal injury,” European Journal of Clinical Investigation, vol. 45, no. 3, pp. 294–302, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Havasi and S. C. Borkan, “Apoptosis and acute kidney injury,” Kidney International, vol. 80, no. 1, pp. 29–40, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Linkermann, G. Chen, G. Dong, U. Kunzendorf, S. Krautwald, and Z. Dong, “Regulated cell death in AKI,” Journal of the American Society of Nephrology, vol. 25, no. 12, pp. 2689–2701, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Akcay, Q. Nguyen, and C. L. Edelstein, “Mediators of inflammation in acute kidney injury,” Mediators of Inflammation, vol. 2009, Article ID 137072, 12 pages, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. G. P. Kaushal and S. V. Shah, “Autophagy in acute kidney injury,” Kidney International, vol. 89, no. 4, pp. 779–791, 2016. View at Publisher · View at Google Scholar
  8. R. Inagi, “Endoplasmic reticulum stress in the kidney as a novel mediator of kidney injury,” Nephron—Experimental Nephrology, vol. 112, no. 1, pp. e1–e9, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Schröder and R. J. Kaufman, “The mammalian unfolded protein response,” Annual Review of Biochemistry, vol. 74, pp. 739–789, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Xu, M. Guo, W. Jiang et al., “Endoplasmic reticulum stress and its effects on renal tubular cells apoptosis in ischemic acute kidney injury,” Renal Failure, vol. 38, no. 5, pp. 831–837, 2016. View at Publisher · View at Google Scholar
  11. D. Luo, Y. Shi, J. Wang et al., “7,8-dihydroxyflavone protects 6-OHDA and MPTP induced dopaminergic neurons degeneration through activation of TrkB in rodents,” Neuroscience Letters, vol. 620, pp. 43–49, 2016. View at Publisher · View at Google Scholar
  12. L. Gao, M. Tian, H.-Y. Zhao et al., “TrkB activation by 7, 8-dihydroxyflavone increases synapse AMPA subunits and ameliorates spatial memory deficits in a mouse model of Alzheimer's disease,” Journal of Neurochemistry, vol. 136, no. 3, pp. 620–636, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. M. D. Sconce, M. J. Churchill, C. Moore, and C. K. Meshul, “Intervention with 7,8-dihydroxyflavone blocks further striatal terminal loss and restores motor deficits in a progressive mouse model of Parkinson's disease,” Neuroscience, vol. 290, pp. 454–471, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Bollen, T. Vanmierlo, S. Akkerman, C. Wouters, H. M. W. Steinbusch, and J. Prickaerts, “7,8-Dihydroxyflavone improves memory consolidation processes in rats and mice,” Behavioural Brain Research, vol. 257, pp. 8–12, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. J. C. Zhang, W. Yao, and K. Hashimoto, “Brain-derived neurotrophic factor (BDNF)—TrkB signaling in inflammation-related depression and potential therapeutic targets,” Current Neuropharmacology, vol. 14, no. 7, pp. 721–731, 2016. View at Publisher · View at Google Scholar
  16. C. Liu, C. B. Chan, and K. Ye, “7,8-Dihydroxyflavone, a small molecular TrkB agonist, is useful for treating various BDNF-implicated human disorders,” Translational Neurodegeneration, vol. 5, no. 1, article 2, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. J. W. Choi, C. W. Lee, J. Lee, D. J. Choi, J. K. Sohng, and Y. I. Park, “7,8-Dihydroxyflavone inhibits adipocyte differentiation via antioxidant activity and induces apoptosis in 3T3-L1 preadipocyte cells,” Life Sciences, vol. 144, pp. 103–112, 2016. View at Publisher · View at Google Scholar · View at Scopus
  18. V. K. Gupta, Y. You, J. C. Li, A. Klistorner, and S. L. Graham, “Protective effects of 7,8-dihydroxyflavone on retinal ganglion and RGC-5 cells against excitotoxic and oxidative stress,” Journal of Molecular Neuroscience, vol. 49, no. 1, pp. 96–104, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. J. I. S. Kang, I. L.-W. Choi, M. H. O. Han et al., “The cytoprotective effects of 7,8-dihydroxyflavone against oxidative stress are mediated by the upregulation of Nrf2-dependent HO-1 expression through the activation of the PI3K/Akt and ERK pathways in C2C12 myoblasts,” International Journal of Molecular Medicine, vol. 36, no. 2, pp. 501–510, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. B. Wang, Q. Zhang, R. Yao, X. Liu, and Z. Qu, “7, 8-Dihydroxyflavone protects an endothelial cell line from H2O2 damage,” PLoS ONE, vol. 10, no. 8, Article ID e0135345, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Lee, J.-C. Shin, K.-H. Kim, Y. H. Choi, J.-I. Chae, and J.-H. Shim, “Apoptotic effects of 7,8-dihydroxyflavone in human oral squamous cancer cells through suppression of Sp1,” Oncology Reports, vol. 33, no. 2, pp. 631–638, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Y. Park, G.-Y. Kim, T. K. Kwon et al., “Apoptosis induction of human leukemia U937 cells by 7,8-dihydroxyflavone hydrate through modulation of the Bcl-2 family of proteins and the MAPKs signaling pathway,” Mutation Research, vol. 751, no. 2, pp. 101–108, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Saikumar and M. A. Venkatachalam, “Role of apoptosis in hypoxic/ischemic damage in the kidney,” Seminars in Nephrology, vol. 23, no. 6, pp. 511–521, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. W. C. Earnshaw, L. M. Martins, and S. H. Kaufmann, “Mammalian caspases: structure, activation, substrates, and functions during apoptosis,” Annual Review of Biochemistry, vol. 68, pp. 383–424, 1999. View at Publisher · View at Google Scholar · View at Scopus
  25. C.-H. Wu, T.-H. Hung, C.-C. Chen et al., “Post-injury treatment with 7,8-dihydroxyflavone, a TrkB receptor agonist, protects against experimental traumatic brain injury via PI3K/Akt signaling,” PLoS ONE, vol. 9, no. 11, Article ID e113397, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. X.-H. Han, M.-N. Cheng, L. Chen et al., “7,8-Dihydroxyflavone protects PC12 cells against 6-hydroxydopamine-induced cell death through modulating PI3K/Akt and JNK pathways,” Neuroscience Letters, vol. 581, pp. 85–88, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Uluç, P. Kendigelen, E. Fidan et al., “TrkB receptor agonist 7, 8 dihydroxyflavone triggers profound gender-dependent neuroprotection in mice after perinatal hypoxia and ischemia,” CNS and Neurological Disorders—Drug Targets, vol. 12, no. 3, pp. 360–370, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. S.-W. Jang, X. Liu, M. Yepes et al., “A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 6, pp. 2687–2692, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. B. Wang, N. Wu, F. Liang et al., “7,8-Dihydroxyflavone, a small-molecule tropomyosin-related kinase B (TrkB) agonist, attenuates cerebral ischemia and reperfusion injury in rats,” Journal of Molecular Histology, vol. 45, no. 2, pp. 129–140, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. N. Chitranshi, V. Gupta, S. Kumar, and S. L. Graham, “Exploring the molecular interactions of 7,8-dihydroxyflavone and its derivatives with TrkB and VEGFR2 proteins,” International Journal of Molecular Sciences, vol. 16, no. 9, pp. 21087–21108, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Dimke, M. A. Sparks, B. R. Thomson, S. Frische, T. M. Coffman, and S. E. Quaggin, “Tubulovascular cross-talk by vascular endothelial growth factor a maintains peritubular microvasculature in kidney,” Journal of the American Society of Nephrology, vol. 26, no. 5, pp. 1027–1038, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. B. F. Schrijvers, A. Flyvbjerg, and A. S. De Vriese, “The role of vascular endothelial growth factor (VEGF) in renal pathophysiology,” Kidney International, vol. 65, no. 6, pp. 2003–2017, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. N. Ferrara, “Role of vascular endothelial growth factor in the regulation of angiogenesis,” Kidney International, vol. 56, no. 3, pp. 794–814, 1999. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Hakroush, M. J. Moeller, F. Theilig et al., “Effects of increased renal tubular Vascular Endothelial Growth Factor (VEGF) on fibrosis, cyst formation, and glomerular disease,” The American Journal of Pathology, vol. 175, no. 5, pp. 1883–1895, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. S.-L. Lin, F.-C. Chang, C. Schrimpf et al., “Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis,” The American Journal of Pathology, vol. 178, no. 2, pp. 911–923, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. M. J. U. Ryu, K. A. H. Kang, M. J. Piao et al., “7,8-Dihydroxyflavone protects human keratinocytes against oxidative stress-induced cell damage via the ERK and PI3K/Akt-mediated Nrf2/HO-1 signaling pathways,” International Journal of Molecular Medicine, vol. 33, no. 4, pp. 964–970, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. T. Tsai, A. Klausmeyer, R. Conrad et al., “7,8-Dihydroxyflavone leads to survival of cultured embryonic motoneurons by activating intracellular signaling pathways,” Molecular and Cellular Neuroscience, vol. 56, pp. 18–28, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. Chen and X.-Y. Du, “Functional properties and intracellular signaling of CCN1/Cyr61,” Journal of Cellular Biochemistry, vol. 100, no. 6, pp. 1337–1345, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. Y. Muramatsu, M. Tsujie, Y. Kohda et al., “Early detection of cysteine rich protein 61 (CYR61, CCN1) in urine following renal ischemic reperfusion injury,” Kidney International, vol. 62, no. 5, pp. 1601–1610, 2002. View at Publisher · View at Google Scholar · View at Scopus
  40. Y.-J. Lee, D. M. Lee, and S.-H. Lee, “Production of Cyr61 protein is modulated by extracellular acidification and PI3K/Akt signaling in prostate carcinoma PC-3 cells,” Food and Chemical Toxicology, vol. 58, pp. 169–176, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. A. A. Sabile, M. J. E. Arlt, R. Muff et al., “Caprin-1, a novel Cyr61-interacting protein, promotes osteosarcoma tumor growth and lung metastasis in mice,” Biochimica et Biophysica Acta—Molecular Basis of Disease, vol. 1832, no. 8, pp. 1173–1182, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. Y. Di, Y. Zhang, Q. Nie, and X. Chen, “CCN1/Cyr61-PI3K/AKT signaling promotes retinal neovascularization in oxygen-induced retinopathy,” International Journal of Molecular Medicine, vol. 36, no. 6, pp. 1507–1518, 2015. View at Publisher · View at Google Scholar · View at Scopus
  43. L. E. H. Smith, “Pathogenesis of retinopathy of prematurity,” Acta Paediatrica, Supplement, vol. 91, no. 437, pp. 26–28, 2001. View at Google Scholar · View at Scopus
  44. B.-R. Lin, C.-C. Chang, L.-R. Chen et al., “Cysteine-rich 61 (CCN1) enhances chemotactic migration, transendothelial cell migration, and intravasation by concomitantly up-regulating chemokine receptor 1 and 2,” Molecular Cancer Research, vol. 5, no. 11, pp. 1111–1123, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. M.-T. Lin, I.-H. Kuo, C.-C. Chang et al., “Involvement of hypoxia-inducing factor-1α-dependent plasminogen activator inhibitor-1 up-regulation in Cyr61/CCN1-induced gastric cancer cell invasion,” The Journal of Biological Chemistry, vol. 283, no. 23, pp. 15807–15815, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Hwang, H.-J. Lee, G. Kim, K.-J. Won, Y. S. Park, and I. Jo, “CCN1 acutely increases nitric oxide production via integrin αvβ3-Akt-S6K-phosphorylation of endothelial nitric oxide synthase at the serine 1177 signaling axis,” Free Radical Biology and Medicine, vol. 89, pp. 229–240, 2015. View at Publisher · View at Google Scholar · View at Scopus